| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |